DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takedomi, S.
Right arrow Articles by Sawada, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takedomi, S.
Right arrow Articles by Sawada, Y.

Vol. 26, Issue 4, 318-323, April 1998

Quantitative Prediction of the Interaction of Midazolam and Histamine H2 Receptor Antagonists in Rats

Sayuri Takedomi, Hirotami Matsuo, Katsuhiro Yamano, Koujirou Yamamoto, Tatsuji Iga, and Yasufumi Sawada

Faculty of Pharmaceutical Sciences, Kyushu University (S.T., H.M., Y.S.), and Department of Pharmacy, University of Tokyo Hospital, Faculty of Medicine, University of Tokyo (Ka.Y., Ko.Y., T.I.)

To quantitatively evaluate drug-drug interactions involving metabolic processes in the liver, we attempted to predict the increasing ratio of the plasma concentration of midazolam (MDZ) in the presence of cimetidine (CIM) or nizatidine (NZD) in rats. Under steady-state conditions for the plasma concentration of CIM or NZD, MDZ was administered through the portal vein. The AUC of MDZ in the presence of CIM was 2.5-fold higher than that in the absence of CIM. There was no effect of NZD on the AUC of MDZ. The liver/plasma concentration ratios for CIM and NZD were 4.0 and 2.7, respectively. The estimated liver unbound concentration (CH,f)/plasma unbound concentration (Cp,f) ratios for CIM and NZD were 1.9 and 2.4, respectively, suggesting concentrative hepatic accumulation of both drugs. The oxidative metabolism of MDZ in rat liver microsomes was competitively inhibited by CIM or NZD, and the Ki values of CIM and NZD were 110 and 2600 µM, respectively. Based on these data obtained in vivo and in vitro, the increasing ratios for MDZ in the presence of CIM or NZD were predicted using the equations Rp = 1 + Cp,f/Ki and RH = 1 + CH,f/Ki. The observed increasing ratios in the presence of CIM were very close to RH, compared with Rp. However, Cp,f and CH,f were much less than Ki and there was no difference between Rp and RH in the presence of NZD. Consequently, Cp,f and CH,f were greater than or equal to Ki and Cp,f was not equal to CH,f, as in the presence of CIM, and it was indicated that CH,f was more suitable for quantitatively predicting the drug-drug interactions than was Cp,f.

Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Drug Metab. Dispos.Home page
K. Shintaku, S. Hori, M. Tsujimoto, H. Nagata, S. Satoh, K. Tsukimori, H. Nakano, T. Fujii, Y. Taketani, H. Ohtani, et al.
Transplacental Pharmacokinetics of Diclofenac in Perfused Human Placenta
Drug Metab. Dispos., May 1, 2009; 37(5): 962 - 968.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
K. Shintaku, Y. Arima, Y. Dan, T. Takeda, K. Kogushi, M. Tsujimoto, H. Nagata, S. Satoh, K. Tsukimori, H. Nakano, et al.
Kinetic Analysis of the Transport of Salicylic Acid, a Nonsteroidal Anti-inflammatory Drug, across Human Placenta
Drug Metab. Dispos., May 1, 2007; 35(5): 772 - 778.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
A. A. Shaw, S. D. Hall, M. R. Franklin, and R. E. Galinsky
The Influence of L-Glutamine on the Depression of Hepatic Cytochrome P450 Activity in Male Rats Caused by Total Parenteral Nutrition
Drug Metab. Dispos., February 1, 2002; 30(2): 177 - 182.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
K. Yamano, K. Yamamoto, M. Katashima, H. Kotaki, S. Takedomi, H. Matsuo, H. Ohtani, Y. Sawada, and T. Iga
Prediction of Midazolam{---}cyp3a Inhibitors Interaction in the Human Liver from in Vivo/in Vitro Absorption, Distribution, and Metabolism Data
Drug Metab. Dispos., April 1, 2001; 29(4): 443 - 452.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
K. Yamano, K. Yamamoto, H. Kotaki, S. Takedomi, H. Matsuo, Y. Sawada, and T. Iga
Quantitative Prediction of Metabolic Inhibition of Midazolam by Erythromycin, Diltiazem, and Verapamil in Rats: Implication of Concentrative Uptake of Inhibitors into Liver
J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 1118 - 1126.
[Abstract] [Full Text]

Home page
 Drug Metab. Dispos.Home page
K. Yamano, K. Yamamoto, H. Kotaki, S. Takedomi, H. Matsuo, Y. Sawada, and T. Iga
Correlation between In Vivo and In Vitro Hepatic Uptake of Metabolic Inhibitors of Cytochrome P-450 in Rats
Drug Metab. Dispos., November 1, 1999; 27(11): 1225 - 1231.
[Abstract] [Full Text]

Home page
 Antimicrob. Agents Chemother.Home page
H. Kita, H. Matsuo, H. Takanaga, J. Kawakami, K. Yamamoto, T. Iga, M. Naito, T. Tsuruo, A. Asanuma, K. Yanagisawa, et al.
In Vivo and In Vitro Toxicodynamic Analyses of New Quinolone-and Nonsteroidal Anti-Inflammatory Drug-Induced Effects on the Central Nervous System
Antimicrob. Agents Chemother., May 1, 1999; 43(5): 1091 - 1097.
[Abstract] [Full Text]

Home page
 Drug Metab. Dispos.Home page
K. Yamano, K. Yamamoto, H. Kotaki, Y. Sawada, and T. Iga
Quantitative Prediction of Metabolic Inhibition of Midazolam by Itraconazole and Ketoconazole in Rats: Implication of Concentrative Uptake of Inhibitors into Liver
Drug Metab. Dispos., March 1, 1999; 27(3): 395 - 402.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics.